Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-119,100
Closed -$14.2M 5154
2025
Q1
$14.2M Buy
+119,100
New +$14.8M 0.02% 858
2024
Q2
Sell
-85,700
Closed -$11.1M 4730
2024
Q1
$11.1M Sell
85,700
-134,200
-61% -$16.2M 0.02% 934
2023
Q4
$25.1M Buy
219,900
+184,900
+528% +$18.5M 0.05% 461
2023
Q3
$3.19M Buy
+35,000
New +$3.61M 0.01% 1476

Other funds holding XYL

Squarepoint's XYL Position: Q1 2026 in Review

Squarepoint reduced its Xylem (XYL) stake by 60% in Q1 2026, selling an estimated $24.5M and leaving 125,453 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #854.

Squarepoint first reported a position in XYL in Q4 2015 and has held it in 30 quarters since. The position peaked at $51.8M in Q2 2023. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Squarepoint held 125,453 shares of Xylem worth $15M as of Q1 2026.
  • Squarepoint sold 186,487 Xylem shares in Q1 2026, an estimated $24.5M.
  • Xylem made up 0.02% of Squarepoint's portfolio in Q1 2026, its #854 holding.
  • Squarepoint first reported a position in Xylem in Q4 2015 and has held it in 30 quarters since.
  • Squarepoint's Xylem position peaked at $51.8M in Q2 2023.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.